Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Kelly Nelson Image

      Kelly Nelson, MD

      Department of Dermatology, Division of Internal Medicine

      Present Title & Affiliation

      Primary Appointment

      Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Associate Medical Director, Dermatology, Melanoma and Skin Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2004University of North Carolina School of Medicine, Chapel Hill, North Carolina, US, MD
      2000Davidson College, Davidson, North Carolina, US, Biology; Concentration in Medical Humanities, BS

      Postgraduate Training

      2007-2008Chief Resident, Training Program, University of North Carolina Health Care, Chapel Hill, North Carolina
      2005-2008Clinical Residency, Dermatology, University of North Carolina Health Care, Chapel Hill, North Carolina
      2004-2005Clinical Internship, Internal Medicine, University of North Carolina Health Care, Chapel Hill, North Carolina

      Licenses & Certifications

      2014Texas Medical Board
      2008American Board of Dermatology
      2005Not specified

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Dermatology, MD Anderson Cancer Center, Houston, TX, 2019 - 2022

      Clinical Associate Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019

      Associate Professor, Dermatology, Duke University Medical Center, Durham, NC, 2013 - 2014

      Attending Dermatologist, Dermatology, Durham Veterans Affairs Medical Center, Durham, NC, 2008 - 2013

      Assistant Professor, Dermatology, Duke University Medical Center, Durham, NC, 2008 - 2013

      Administrative Appointments/Responsibilities

      Associate Medical Director, Dermatology, Melanoma and Skin Center, Houston, TX, 2022 - Present

      Co-Chair, Melanoma Moonshot, Flagship 1: Melanoma Prevention and Early Diagnosis, MD Anderson Cancer Center, Houston, TX, 2017 - 2022

      Vice Chair for Clinical Operations, Dermatology, Duke University Medical Center, Durham, NC, 2012 - 2014

      Medical Director, Dermatology, Duke University Medical Center, 3k Clinic, Durham, NC, 2011 - 2014

      Chair, Dermatology, Duke University Medical Center, Safety Committee, Durham, NC, 2010 - 2014

      Committee Chair, Dermatology, Duke University Medical Center, Service Excellence Committee, Durham, NC, 2010 - 2014

      Chair, Duke University Medical Center Multidisciplinary Melanoma Tumor Board, Durham, NC, 2008 - 2014

      Director, Dermatology, Pigmented Lesions Clinic, Duke University Medical Center, Durham, NC, 2008 - 2014

      Other Professional Positions

      Member, Melanoma Guidelines Working Group, Clinical Guidelines Committee, American Academy of Dermatology, Rosemont, IL, 2023 - Present

      Member, Education Committee, International Dermoscopy Society, Graz, 2022 - Present

      Co-Chair, Technique Working Group, International Skin Imaging Collaborative, Houston, TX, 2021 - Present

      Inaugural Co-Chair, Education Working Group, International Skin Imaging Collaborative, Houston, TX, 2021 - Present

      Member, DICOM cutaneous imaging standards working group, International Skin Imaging Collaborative, Graz, 2019 - Present

      Member, PDQ Cancer Genetics Editorial Board, National Cancer Institute, Rosemont, IL, 2019 - Present

      Secretary, Pigmented Lesion Subcommittee, Melanoma Prevention Working Group, ECOG/SWOG, San Antonio, TX, 2017 - Present

      Member, Melanoma Quality Measure Set Workgroup, Performance Measurement Task Force, American Academy of Dermatology, Houston, TX, 2017 - 2019

      Member, Pigmented Lesion Subcommittee, Melanoma Prevention Working Group, ECOG/SWOG, San Antonio, TX, 2014 - Present

      Member, Non-Melanocytic Skin Cancer Quality Measure Set Workgroup, Performance Measurement Task Force American Academy of Dermatology, Rosemont, IL, 2013 - 2015

      Co-chair, Academic Leadership Committee, Women's Dermatology Society, Milwaukee, WI, 2012 - 2017

      Member, Editorial DSAP Board, Dermatology Self-Assessment Program, American Academy of Dermatology, Rosemont, IL, 2010 - 2012

      Member, PDQ Cancer Genetics Editorial Board, National Cancer Institute, Bethesda, MD, 2009 - 2013

      Member, Non-Melanoma Skin Cancer Panel, National Comprehensive Cancer Network, Plymouth, PA, 2008 - 2014

      Extramural Institutional Committee Activities

      Peer Messenger, Center for Professionalism Support and Success, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2024 - Present

      Member, Education Committee, Department of Internal Medicine, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Member, Denials Prevention Subcommittee, Clinical Revenue Cycle Committee,MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2020 - 2023

      Member, Medical Media Consolidation Project Steering Committee, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2020 - 2022

      Team Lead, Documentation/Coding Compliance Working Group, Department of Dermatology, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2019 - Present

      Member, Clinical Cycle Revenue Committee, Physician Revenue Service, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2019 - 2023

      Member, Denials Prevention Committee, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2017 - 2019

      Member, Private Diagnostics Clinic (PDC) Access Improvement Council, Duke University, The University of Texas MD Anderson Cancer Center, 2013 - 2014

      Member, EPIC Provider Optimization Council, The University of Texas MD Anderson Cancer Center, 2013 - 2014

      Member, EPIC Physicians Advisory Council Steering Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2014

      Member, Institutional Review Board, Duke University Medical Center, The University of Texas MD Anderson Cancer Center, 2009 - 2012

      Honors & Awards

      2021Rising Star, World Congress of Dermoscopy
      2021The Julie and Ben Rogers Award for Excellence in Cancer Prevention, The University of Texas MD Anderson Cancer Center,
      2020Honorable Mention, Leading Mentor in Cancer Prevention Award, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center
      2019Outstanding Mentor, UT Health School of Dentistry at Houston, Project ECHO Dental & Oral Health Geriatrics Hub
      2019President’s Recognition of Faculty Excellence, Prevention Outreach,The University of Texas MD Anderson Cancer Center
      2019Faculty Excellence Award, Excellence in Education, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center
      2011First Place, Patient Safety Project, Duke Medicine Patient Safety Quality Conference
      2010NIH Merit Award Recipient, Group Award, PDQ Editorial Board
      2010Women's Dermatologic Society Mentorship Grant
      2009J. Lamar Callaway Teaching Award, Department of Dermatology, Duke University

      Professional Memberships

      Cancer Alliance of Texas

      2021 - Present

      Houston Dermatological Society

      2018 - Present

      American Professors of Dermatology

      2018 - Present

      International Dermoscopy Society

      2017 - Present

      International Skin Imaging Collaborative

      2017 - Present

      International Dermoscopy Society

      2016 - Present

      Texas Dermatology Society

      2016 - Present

      American Society of Dermatologic Surgeons

      2013 - Present

      Women's Dermatology Society

      2008 - Present

      Society of Investigative Dermatology

      2008 - Present

      North Carolina Medical Society

      2008 - 2014

      American Academy of Dermatology

      2005 - Present

      Selected Presentations & Talks

      Regional Presentations

      1. 2024. Invited Speaker, High Yield Dermoscopy. Conference. Banner MD Anderson Cancer Center, TW Lewis Melanoma Center of Excellence. Tucson, AZ, US.
      2. 2019. Invited Speaker, High Yield Dermoscopy. Conference. Oklahoma Dermatology Association. Tulsa, OK, US.
      3. 2017. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Artificial Intelligence and Skin Cancer Diagnosis. Conference. North Carolina Dermatology Association. The Homestead, VA, US.
      4. 2013. Invited Speaker, Vulvar and Mucosal Melanoma. Conference. Univeristy of North Carolina School of Medicine. Chapel Hill, NC, US.
      5. 2011. Invited Speaker, Safety and Quality for the Dermatologist. Conference. North Carolina Dermatology Association. Kiawah, SC, US.
      6. 2011. Invited Speaker, Utility of Confocal Microscopy in the Adult Patient, Sixth Annual Conference on Melanoma. Conference. University of North Carolina School of Medicine. Chapel Hill, NC, US.
      7. 2011. Invited Speaker, Overview of Skin Cancer Diagnosis Technologies. Conference. North Carolina Dermatology Association. Pinehurst, NC, US.
      8. 2010. Invited Speaker, Reflectance Confocal Microscopy. Conference. SouthEastern Consortium for Dermatology. Durham, NC, US.
      9. 2010. Invited Speaker, Point-Counterpoint: Genetic Testing in Melanoma. Conference. North Carolina Dermatology Association. Asheville, NC, US.
      10. 2010. Invited Speaker, Real-time Confocal Microscopy. Conference. Melanoma Research Alliance. Las Vegas, NV, US.
      11. 2009. Invited Speaker, New Imaging Directions in Dermatology. Conference. SouthEastern Consortium for Dermatology. Durham, NC, US.
      12. 2009. Invited Speaker, Non-invasive In-Vivo Investigational Technologies. Conference. Steifel Dermatology Research. Chapel Hill, NC, US.

      National Presentations

      1. 2024. Invited Speaker, The Changing Landscape of Early-Stage Melanoma Management. Total Body Photography Overview. Invited. American Academy of Dermatology. San Diego, CA, US.
      2. 2024. Invited Speaker, Intermediate Dermoscopy: Taking your Skills to the Next Level. Overview of Pink and Brown Lesion Dermoscopy. Invited. American Academy of Dermatology. San Diego, CA, US.
      3. 2024. Invited Speaker, Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines, Non-surgical Management Options for Lentigo Maligna Melanoma. Invited. American Academy of Dermatology. San Diego, CA, US.
      4. 2024. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. San Diego, CA, US.
      5. 2023. Invited Speaker, Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines, Non-surgical Management Options for Lentigo Maligna Melanoma. Invited. American Academy of Dermatology. New Orleans, LA, US.
      6. 2023. Invited Speaker, Intermediate Dermoscopy: Taking your Skills to the Next Level. Overview of Pink and Brown Lesion Dermoscopy. Invited. American Academy of Dermatology. New Orleans, LA, US.
      7. 2023. Invited Speaker, The Changing Landscape of Early-Stage Melanoma Management. Total Body Photography Overview. Invited. American Academy of Dermatology. New Orleans, LA, US.
      8. 2023. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. New Orleans, LA, US.
      9. 2022. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. Boston, MA, US.
      10. 2022. Invited Speaker, Intermediate Dermoscopy: Taking your Skills to the Next Level. Overview of Pink and Brown Lesion Dermoscopy. Invited. American Academy of Dermatology. Boston, MA, US.
      11. 2022. Invited Speaker, Malignant Melanoma: Molecular Diagnostics, Emerging Therapies, and the Microbiome, Updates on the Impact of the Gut Microbiome. Invited. American Academy of Dermatology. Boston, MA, US.
      12. 2022. Invited Speaker, How Far Can We Get With Medical Imaging, Overview of Dermoscopic Imaging. Invited. American Academy of Dermatology. Boston, MA, US.
      13. 2022. Invited Speaker, Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines, Non-surgical Management Options for Lentigo Maligna Melanoma. Invited. American Academy of Dermatology. Boston, MA, US.
      14. 2021. Invited Speaker, How Far Can We Get With Medical Imaging, Overview of Dermoscopic Imaging. Invited. Conference cancelled due to COVID-19. San Francisco, CA, US.
      15. 2021. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. Conference cancelled due to COVID-19. San Francisco, CA, US.
      16. 2021. Invited Speaker, Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines, Non-surgical Management Options for Lentigo Maligna Melanoma. Invited. Conference cancelled due to COVID-19. San Francisco, CA, US.
      17. 2020. Plenary Speaker, An evidence-based virtual Learning Management System dermoscopy educational intervention for US Dermatology residents, Virtual Annual Meeting. Invited. Association of Professors of Dermatology, US.
      18. 2020. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases, American Academy of Dermatology. Invited. Conference cancelled due to COVID-19. Denver, CO, US.
      19. 2020. Invited Speaker, Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines, Non-surgical Management Options for Lentigo Maligna Melanoma. Invited. Conference cancelled due to COVID-19, US.
      20. 2020. Invited Speaker, How Far Can We Get With Medical Imaging, Overview of Dermoscopic Imaging. Invited. Conference cancelled due to COVID-19. Denver, CO, US.
      21. 2019. Invited Speaker, Project ECHO and Early Melanoma Detection. Invited. ECOG/SWOG Melanoma Prevention Working Group. Salt Lake City, UT, US.
      22. 2019. Invited Speaker, Advances in melanoma education and tools for self-monitoring, Advances in Melanoma Symposium. Invited. American Academy of Dermatology. New York, NY, US.
      23. 2019. Invited Speaker, Non-surgical Management Options for Lentigo Maligna Melanoma, Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Invited. American Academy of Dermatology. Washington, DC, US.
      24. 2019. Invited Speaker, The University of Texas MD Anderson Cancer Center: The Quest for Data. MetaECHO Conference. Invited. The University of Texas MD Anderson Cancer Center. Albuquerque, NM, US.
      25. 2019. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. Washington, DC, US.
      26. 2019. Invited Speaker, Innovative Ways to Measure the Impact of ECHO Programs: Examples from the ECHO Cancer Collaborative, Dermatology Early Melanoma Detection Curriculum. Invited. MetaECHO Conference. Albuquerque, NM, US.
      27. 2018. Invited Speaker, Advances in Melanoma, Advances in Melanoma Education. Invited. American Academy of Dermatology, Summer Meeting. Chicago, IL, US.
      28. 2018. Invited Speaker, Practical Management of Melanoma and Dysplastic Nevi, Practical Dermoscopy Tips. Invited. American Academy of Dermatology, Summer Meeting. Chicago, IL, US.
      29. 2018. Invited Speaker, Practical Management of Atypical Melanocytic Lesions, Management of Atypical Truncal and Extremity Lesions. Invited. American Academy of Dermatology. San Diego, CA, US.
      30. 2018. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. San Diego, CA, US.
      31. 2017. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. Orlando, FL, US.
      32. 2017. Invited Speaker, Diagnosis, Treatment and Prevention of Errors in Dermatologic Practice, Technical Errors: recognizing and preventing. Invited. American Academy of Dermatology. Orlando, FL, US.
      33. 2017. Invited Speaker, Practical Management of Atypical Melanocytic Lesions, Management of Atypical Truncal and Extremity Lesions. Invited. American Academy of Dermatology. Orlando, FL, US.
      34. 2016. Invited Speaker, Practical Management of Atypical Melanocytic Lesions, Management of Atypical Truncal and Extremity Lesions,. Invited. American Academy of Dermatology. Washington, DC, US.
      35. 2016. Invited Speaker, Patient Safety and Communication , Effective Communication Skills for Safe Specimen Management. Invited. American Academy of Dermatology. Washington, DC, US.
      36. 2016. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. Washington, DC, US.
      37. 2015. Invited Speaker, Melanoma Management Controversies, Sentinel Node Biopsy. Invited. American Academy of Dermatology. San Francisco, CA, US.
      38. 2015. Invited Speaker, Practical Management of Atypical Melanocytic Lesions, Management of Atypical Truncal and Extremity Lesions. Invited. American Academy of Dermatology. San Francisco, CA, US.
      39. 2015. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. San Francisco, CA, US.
      40. 2014. Invited Speaker, Practical Management of Atypical Melanocytic Lesions, Management of Atypical Truncal and Extremity Lesions. Invited. American Academy of Dermatology. Denver, CO, US.
      41. 2014. Invited Speaker, Dermoscopy for the Non-Dermoscopist, Review of Unknown Cases. Invited. American Academy of Dermatology. Denver, CO, US.
      42. 2014. Invited Speaker, Hot Topics in Melanoma, Review of Non-Invasive Diagnostic Technologies. Invited. American Academy of Dermatology. Denver, CO, US.
      43. 2014. Invited Speaker, Safety and Continuous Improvement in Dermatology. Invited. American Osteopathic College of Dermatology. Dallas, TX, US.
      44. 2013. Invited Speaker, Practical Management of Atypical Melanocytic Lesions, Management of Atypical Truncal/Extremity Melanocytic Lesions. Invited. American Academy of Dermatology. Miami, FL, US.
      45. 2012. Invited Speaker, Dermoscopy: Case Presentations and Unknowns, Summer Meeting. Invited. American Academy of Dermatology. Boston, MA, US.
      46. 2012. Invited Speaker, Dermoscopy for the Non-Dermoscopist. Invited. American Academy of Dermatology. San Diego, CA, US.
      47. 2012. Invited Speaker, Practical Management of Atypical Melanocytic Lesions,Management of Atypical Truncal/Extremity Melanocytic Lesions. Invited. American Academy of Dermatology. San Diego, CA, US.

      International Presentations

      1. 2021. Plenary Speaker, Dermoscopy Education: Changing the Paradigm, Rising Star Plenary Lecture, Virtual Meeting. Invited. World Congress of Dermoscopy, US.
      2. 2019. invited Speaker, Overview of US Dermoscopy Education. Invited. International Dermoscopy Society Meeting. Washington, US.

      Formal Peers

      1. 2023. Visiting Professor, Geospatial Approaches to Melanoma Control: Practical Dermoscopy. Visiting, US.
      2. 2023. Visiting Professor, Geospatial Approaches to Melanoma Control: Practical Dermoscopy. Visiting, US.
      3. 2022. Visiting Professor, Practical Dermoscopy: learning via clinical comparators. Visiting, US.
      4. 2020. Keynote Speaker, Skin Cancer Prevention Friends Meeting. Visiting, US.
      5. 2017. Keynote Speaker Melanoma Patient Symposium. Visiting, US.
      6. 2014. Grand Rounds, EPIC Go-live Organization. We survived and you will too!. Visiting, US.
      7. 2014. Grand Rounds Dermoscopy and Skin Cancer. Visiting, US.
      8. 2012. Grand Rounds Management of the Complex Cutaneous Oncology Patient. Visiting, US.
      9. 2012. Visiting Professorship Practical Dermoscopy for Real World Dermatology. Visiting, US.
      10. 2012. Grand Rounds Dermoscopy: Beyond the Basics. Visiting, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2023 - 2028
      Title:Geospatial Approaches to Early Melanoma Detection - the GAMED Project, Individual Investigator Research Award for Prevention and Early Detection
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-PI
      Date: 2023 - 2025
      Title:Quantifying the Impact of Skin Tone on Diagnostic Prediction
      Funding Source:Prevent Cancer Foundation
      Role:Co-I
      Date: 2022 - 2023
      Title:Texas Melanoma Stage at Diagnosis and Geospatial Persistent Poverty
      Funding Source:UT Austin/MD Anderson Cancer Center Collaborative Pilot Project Grant
      Role:Co-PI
      Date: 2021 - 2023
      Title:Exploration of Normal Skin, Actinic keratosis and Squamous Cell Carcinoma RNAseq singatures
      Funding Source:Pre-Cancer Atlas Moonshot Grant, MD Anderson Cancer Center
      Role:Co-PI
      Date: 2021 - 2022
      Title:Project ECHO: Early Melanoma Detection
      Funding Source:MD Anderson Cancer Center
      Role:PI
      Date: 2021 - 2022
      Title:Project ECHO: Early Melanoma Detection Educational Network, Melanoma Secondary Prevention Platform
      Funding Source:Melanoma Moonshot Grant, MD Anderson Cancer Center
      Role:PI
      Date: 2020 - 2021
      Title:Project ECHO: Early Melanoma Detection Educational Network, Melanoma Secondary Prevention Platform
      Funding Source:Melanoma Moonshot Grant, MD Anderson Cancer Center
      Role:PI
      Date: 2019 - 2020
      Title:Project ECHO: Early Melanoma Detection Educational Network, Melanoma Secondary Prevention Platform
      Funding Source:Melanoma Moonshot Grant, MD Anderson Cancer Center
      Role:Principal Investigator-MDACC
      Date: 2018 - 2019
      Title:Project ECHO: Early Melanoma Detection Educational Network, Melanoma Secondary Prevention Platform
      Funding Source:Melanoma Moonshot Grant, MD Anderson Cancer Center
      Role:Principal Investigator-MDACC
      Date: 2017 - 2018
      Title:Project ECHO: Early Melanoma Detection Educational Network, Melanoma Secondary Prevention Platform
      Funding Source:Melanoma Moonshot Grant, MD Anderson Cancer Center
      Role:PI
      Date: 2015
      Title:Comparison of novel automated dermoscopic analysis smart-phone app to genetic profiles of melanoma and precursor melanocytic lesions
      Funding Source:Melanoma Moonshot Program, MD Anderson Cancer Center
      Role:Co-PI
      Date: 2010 - 2012
      Title:Development of web-based dermatology teaching modules for primary care housestaff
      Funding Source:Duke Graduate Medical Education Innovation Grant
      Role:PI
      Date: 2010 - 2012
      Title:Exploration of oncogene expression in new and melanoma of the female reproductive tract
      Funding Source:Women's Dermatologic Society Academic Research Grant
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Turcios Escobar S, Yang R, Nelson KC, Gershenwald JE, Tawbi H, Aung PP, Patel SP, Torres-Cabala CA. Utility of next-generation sequencing in the diagnosis of metastatic melanoma: A case report. J Cutan Pathol 51(9):644-648, 2024. e-Pub 2024. PMID: 38757469.
      2. Seervai RNH, Taylor MM, Rahbar Z, Patel SP, Nelson KC, Prieto VG, Curry JL. Keratosis Pilaris-Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma. JAMA Dermatol 160(6):682-685, 2024. e-Pub 2024. PMID: 38717752.
      3. Liopyris K, Navarrete-Dechent C, Marchetti MA, Rotemberg V, Apalla Z, Argenziano G, Blum A, Braun RP, Carrera C, Codella NCF, Combalia M, Dusza SW, Gutman DA, Helba B, Hofmann-Wellenhof R, Jaimes N, Kittler H, Kose K, Lallas A, Longo C, Malvehy J, Menzies S, Nelson KC, Paoli J, Puig S, Rabinovitz HS, Rishpon A, Russo T, Scope A, Soyer HP, Stein JA, Stolz W, Sgouros D, Stratigos AJ, Swanson DL, Thomas L, Tschandl P, Zalaudek I, Weber J, Halpern AC, Marghoob AA. Expert Agreement on the Presence and Spatial Localization of Melanocytic Features in Dermoscopy. J Invest Dermatol 144(3):531-539.e13, 2024. e-Pub 2024. PMID: 37689267.
      4. Madrigal K, Morris L, Zhang K, Nelson E, Tran T, Galindez M, Duan Z, Adamson AS, Zhao H, Doan HQ, Taylor MM, Bauer C, Nelson KC. Persistent poverty and incidence-based melanoma mortality in Texas. Cancer Causes Control. e-Pub 2024. PMID: 38421511.
      5. Gellatly ZS, Lagha IB, Ternov NK, Berry E, Nelson KC, Seiverling EV. The Role of Dermoscopy in Provider-to-Provider Store-and-Forward Dermatology eConsults: A Scoping Review of the Recent Literature. Curr Dermatol Rep 12(4):169-179, 2023. e-Pub 2023. PMID: 38390375.
      6. Kim K, Reddy S, Osborn L, Frieden IJ, Nelson KC, Nicholas MW, Bailey EE, Dickman M, Working Group IT. A practical guide to clinical photography prior to skin biopsy: key tips and proposed workflow. Arch Dermatol Res 315(9):2661-2667, 2023. e-Pub 2023. PMID: 37530784.
      7. Witt RG, Cass SH, Tran T, Damania A, Nelson EE, Sirmans E, Burton EM, Chelvanambi M, Johnson S, Tawbi HA, Gershenwald JE, Davies MA, Spencer C, Mishra A, Wong MC, Ajami NJ, Peterson CB, Daniel CR, Wargo JA, McQuade JL, Nelson KC. Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma. JAMA Dermatol 159(10):1076-1084, 2023. e-Pub 2023. PMID: 37647056.
      8. Nelson EE, Ryan MP, Nelson KC. Diffuse Pruritic Eruption in an Immunocompromised Patient. Cutis 112(3):E21-E23, 2023. e-Pub 2023. PMID: 37903391.
      9. Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
      10. Kashani-Sabet M, Leachman SA, Stein JA, Arbiser JL, Berry EG, Celebi JT, Curiel-Lewandrowski C, Ferris LK, Grant-Kels JM, Grossman D, Kulkarni RP, Marchetti MA, Nelson KC, Polsky D, Seiverling EV, Swetter SM, Tsao H, Verdieck-Devlaeminck A, Wei ML, Bar A, Bartlett EK, Bolognia JL, Bowles TL, Cha KB, Chu EY, Hartman RI, Hawryluk EB, Jampel RM, Karapetyan L, Kheterpal M, Lawson DH, Leming PD, Liebman TN, Ming ME, Sahni D, Savory SA, Shaikh SS, Sober AJ, Sondak VK, Spaccarelli N, Usatine RP, Venna S, Kirkwood JM. Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing. JAMA Dermatol 159(5):545-553, 2023. e-Pub 2023. PMID: 36920356.
      11. Tran T, Cyr PR, Verdieck A, Lu MD, Ahrns HT, Berry EG, Bowen W, Braun RP, Cusick-Lewis JM, Doan HQ, Donohue VL, Erlich DR, Ferris LK, Harkemanne E, Hartman RI, Holt J, Jaimes N, Joslin TA, Kabaeva Z, Liebman TN, Ludzik J, Marghoob AA, Simpson I, Stein JA, Stulberg DL, Tromme I, Turnquist MJ, Usatine RP, Walker AM, Walker BL, West RF, Wilson ML, Witkowski A, Wu DJ, Seiverling EV, Nelson KC. Expert Consensus Statement on Proficiency Standards for Dermoscopy Education in Primary Care. J Am Board Fam Med 36(1):25-38, 2023. e-Pub 2023. PMID: 36759132.
      12. Black TA, Parbs JR, Teixeira AJ, Cyr P, Nelson KC, Stoddard H, Seiverling EV. Thematic analyses of participant survey responses following dermatology ECHO programs with dermoscopy: Practical tips and lessons learned. Front Digit Health 5:1163556, 2023. e-Pub 2023. PMID: 37035480.
      13. Qian J, Kubicki SL, Curry JL, Jahan-Tigh R, Benjamin R, Heberton M, Nelson KC. Pembrolizumab-induced rash in a patient with angiosarcoma. JAAD Case Rep 29:21-24, 2022. e-Pub 2022. PMID: 36186410.
      14. Najmi M, Brown AE, Harrington SR, Farris D, Sepulveda S, Nelson KC. A systematic review and synthesis of qualitative and quantitative studies evaluating provider, patient, and health care system-related barriers to diagnostic skin cancer examinations. Arch Dermatol Res 314(4):329-340, 2022. e-Pub 2022. PMID: 33913002.
      15. Patel AB, Farooq S, Welborn M, Amaria RN, Chon SY, Diab A, Glitza Oliva IC, Huen AO, Li SQ, Nelson KC, Pacha O, Patel SP, Rapini RP, Tawbi HA, Wong MK, McQuade J, Davies MA, Haydu LE. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit. Cancer 128(5):975-983, 2022. e-Pub 2022. PMID: 34724197.
      16. Nelson KC, Seiverling EV, Gonna N, Berry E, Stoos E, Dorsey CN, Sepulveda S, Vazquez G, Doan HQ, Haydu LE. A Pilot Educational Intervention to Support Primary Care Provider Performance of Skin Cancer Examinations. J Cancer Educ. e-Pub 2022. PMID: 35013902.
      17. Nguyen QD, Starling CT, Baig IT, Koshelev MV, Nelson KC. Online dermatology curriculum experiences among US dermatology residents and faculty. Clin Dermatol 40(6):788-791, 2022. e-Pub 2022. PMID: 35952855.
      18. Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
      19. Keiser MF, Nguyen QD, Masterson WM, Nelson KC. Persistent Facial and Chest Papular and Pustular Eruption in a Stem Cell Transplant Patient. Transplant Direct 7(12):e793, 2021. e-Pub 2021. PMID: 34805495.
      20. Orfaly VE, Berry EG, Stoos ER, Latour E, Becevic M, Black SM, Ferris LK, Geller A, Jacobe H, Nelson KC, Prasad S, Savory S, Smith EH, Swetter SM, Weinstock MA, Xu S, Leachman SA. Melanoma toolkit for early detection for primary care providers: A pilot study. Pigment Cell Melanoma Res 34(5):984-986, 2021. e-Pub 2021. PMID: 33638298.
      21. Atkins MB, Curiel-Lewandrowski C, Fisher DE, Swetter SM, Tsao H, Aguirre-Ghiso JA, Soengas MS, Weeraratna AT, Flaherty KT, Herlyn M, Sosman JA, Tawbi HA, Pavlick AC, Cassidy PB, Chandra S, Chapman PB, Daud A, Eroglu Z, Ferris LK, Fox BA, Gershenwald JE, Gibney GT, Grossman D, Hanks BA, Hanniford D, Hernando E, Jeter JM, Johnson DB, Khleif SN, Kirkwood JM, Leachman SA, Mays D, Nelson KC, Sondak VK, Sullivan RJ, Merlino G, Foundation MR. The State of Melanoma: Emergent Challenges and Opportunities. Clin Cancer Res 27(10):2678-2697, 2021. e-Pub 2021. PMID: 33414132.
      22. Fried LJ, Tan A, Berry EG, Braun RP, Curiel-Lewandrowski C, Curtis J, Ferris LK, Hartman RI, Jaimes N, Kawaoka JC, Kim CC, Lallas A, Leachman SA, Levin A, Lucey P, Marchetti MA, Marghoob AA, Miller D, Nelson KC, Prodanovic E, Seiverling EV, Swetter SM, Savory SA, Usatine RP, Wei ML, Polsky D, Stein JA, Liebman TN. Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts. JAMA Dermatol 157(2):189-197, 2021. e-Pub 2021. PMID: 33404623.
      23. Nelson KC, Brown AE, Herrmann A, Dorsey C, Simon JM, Wilson JM, Savory SA, Haydu LE. Validation of a Novel Cutaneous Neoplasm Diagnostic Self-Efficacy Instrument (CNDSEI) for Evaluating User-Perceived Confidence With Dermoscopy. Dermatol Pract Concept 10(4):e2020088, 2020. e-Pub 2020. PMID: 33150029.
      24. Marques-Piubelli ML, Tetzlaff MT, Nagarajan P, Duke TC, Glitza Oliva IC, Ledesma DA, Aung PP, Torres-Cabala CA, Wistuba II, Prieto VG, Nelson KC, Curry JL. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol 47(10):954-959, 2020. e-Pub 2020. PMID: 32394425.
      25. Farah M, Nelson KC, Tetzlaff MT, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. J Cutan Pathol 47(5):490-493, 2020. e-Pub 2020. PMID: 31930527.
      26. Mejbel HA, Nelson KC, Pradhan D, Ivan D, Zaleski M, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature. J Cutan Pathol 47(1):36-46, 2020. e-Pub 2020. PMID: 31361351.
      27. Manalo IF, Lowe MC, Nelson KC, Chen SC. Triple therapy with intralesional 5-fluorouracil, chemowraps, and acitretin: A well-tolerated option for treatment of widespread cutaneous squamous cell carcinomas on the legs. JAAD Case Rep 5(12):1051-1054, 2019. e-Pub 2019. PMID: 31768411.
      28. Nelson KC, Swetter SM, Saboda K, Chen SC, Curiel-Lewandrowski C. Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis. JAMA Dermatol 155(10):1167-1174, 2019. e-Pub 2019. PMID: 31290958.
      29. Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol 58(9):1045-1052, 2019. e-Pub 2019. PMID: 29152725.
      30. Nelson KC, Gershenwald JE, Savory SA, Wilson JM, Simon JM, Burton EM, Haydu LE. Telementoring and Smart-Phone-Based Answering Systems to Optimize Dermatology Resident Dermoscopy Education. J Am Acad Dermatol 81(2):e27-e28, 2019. e-Pub 2019. PMID: 30703459.
      31. Yélamos O, Navarrete-Dechent C, Marchetti MA, Rogers T, Apalla Z, Bahadoran P, Blázquez-Sánchez N, Busam K, Carrera C, Dusza SW, de la Fouchardière A, Ferrara G, Gerami P, Kittler H, Lallas A, Malvehy J, Millán-Cayetano JF, Nelson KC, Quan VL, Puig S, Stevens H, Thomas L, Marghoob AA. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society. J Am Acad Dermatol 80(6):1585-1593, 2019. e-Pub 2019. PMID: 30244062.
      32. Locke DH, Polsky C, Grove JM, Groffman PM, Nelson KC, Larson KL, Cavender-Bares J, Heffernan JB, Chowdhury RR, Hobbie SE, Bettez ND, Hall SJ, Neill C, Ogden L, O'Neil-Dunne J. Residential household yard care practices along urban-exurban gradients in six climatically-diverse U.S. metropolitan areas. PLoS One 14(11):e0222630, 2019. e-Pub 2019. PMID: 31721782.
      33. Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Meric-Bernstam F, Torres-Cabala C, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol 45(10):786-790, 2018. e-Pub 2018. PMID: 30021048.
      34. Chen WS, Tetzlaff MT, Diwan H, Jahan-Tigh R, Diab A, Nelson K, Glitza IC, Kaunitz GJ, Johnson D, Torres-Cabala C, Pacha O, Taube JM, Maloney K, Prieto VG, Curry JL. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. J Cutan Pathol 45(10):764-773, 2018. e-Pub 2018. PMID: 29943453.
      35. Nelson KC, Grossman D, Kim CC, Chen SC, Curiel-Lewandrowski CN, Grichnik JM, Kirkwood JM, Leachman SA, Marghoob AA, Swetter SM, Venna SS, Ming ME. Management strategies of academic pigmented lesion clinic directors in the United States. J Am Acad Dermatol 79(2):367-369, 2018. e-Pub 2018. PMID: 29307637.
      36. Dolkar T, Trinidad CM, Nelson KC, Amaria RN, Nagarajan P, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Curry JL, Aung PP. Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features. J Cutan Pathol 45(7):539-544, 2018. e-Pub 2018. PMID: 29665030.
      37. Trinidad C, Nelson KC, Glitza Oliva IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Hwu WJ, Prieto VG, Curry JL, Aung PP. Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern. J Cutan Pathol 45(7):504-507, 2018. e-Pub 2018. PMID: 29633300.
      38. Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6(1):14, 2018. e-Pub 2018. PMID: 29433571.
      39. Sundaresan S, Nguyen KT, Nelson KC, Ivan D, Patel AB. Erythema Multiforme Major in a Patient with Metastatic Melanoma Treated with Nivolumab. Dermatol Online J 23(9):9, 2017. e-Pub 2017. PMID: 29469720.
      40. Gershenwald JE, Nelson KC. Skin Cancer: Have melanoma and skin cancer finally met their match?. Nat Rev Clin Oncol 14(5):267-268, 2017. e-Pub 2017. PMID: 28422116.
      41. Truong A, Strazzulla L, March J, Boucher KM, Nelson KC, Kim CC, Grossman D. Reduction in nevus biopsies in patients monitored by total body photography. J Am Acad Dermatol 75(1):135-143.e5, 2016. e-Pub 2016. PMID: 26947450.
      42. Whitworth WW, Hick RW, Nelson KC, Sidhu-Malik NK. Cerebral cavernous malformations associated with cutaneous angiokeratomas and hemangiomas. Cutis 96(5):329-32, 2015. e-Pub 2015. PMID: 26682556.
      43. Choudhry A, Hong J, Chong K, Jiang B, Hartman R, Chu E, Nelson K, Wei ML, Nguyen T. Patients' preferences for biopsy result notification in an era of electronic messaging methods. JAMA Dermatol 151(5):513-21, 2015. e-Pub 2015. PMID: 25831475.
      44. Tseng D, Kim J, Warrick A, Nelson D, Pukay M, Beadling C, Heinrich M, Selim MA, Corless CL, Nelson K. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. J Am Acad Dermatol 71(2):229-36, 2014. e-Pub 2014. PMID: 24842760.
      45. Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Ho AL, Lewis KD, Lydiatt DD, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Perlis CS, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Werchniak AE, Wong SL, Zic JA, McMillian N, Hoffman K, Ho M. Dermatofibrosarcoma protuberans, version 1.2014. J Natl Compr Canc Netw 12(6):863-8, 2014. e-Pub 2014. PMID: 24925197.
      46. Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Ho AL, Lewis KD, Lydiatt DD, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Perlis CS, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Werchniak AE, Wong SL, Zic JA, Hoffmann KG, McMillian NR, Ho M, cancer network NC. Merkel cell carcinoma, version 1.2014. J Natl Compr Canc Netw 12(3):410-24, 2014. e-Pub 2014. PMID: 24616545.
      47. Tcheung WJ, Nelson K, Aldabagh B, Puja P. Pathologic features of pediatric head and neck melanoma. Pediatr Dermatol 30(5):568-73, 2013. e-Pub 2013. PMID: 23627731.
      48. Kim JK, Dotson B, Thomas S, Nelson KC. Standardized patient identification and specimen labeling: a retrospective analysis on improving patient safety. J Am Acad Dermatol 68(1):53-6, 2013. e-Pub 2013. PMID: 22841126.
      49. Tcheung WJ, Selim MA, Herndon JE, Abernethy AP, Nelson KC. Clinicopathologic study of 85 cases of melanoma of the female genitalia. J Am Acad Dermatol 67(4):598-605, 2012. e-Pub 2012. PMID: 22243767.
      50. Miller SJ, Alam M, Andersen JS, Berg D, Bichakjian CK, Bowen GM, Cheney RT, Glass LF, Grekin RC, Ho AL, Kessinger A, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Perlis CS, Shaha AR, Tuli M, Urist MM, Wang LC, Zic JA, Cancer Network NC. Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw 10(3):312-8, 2012. e-Pub 2012. PMID: 22393193.
      51. Kollitz KM, Tcheung WJ, Scheri RP, Selim MA, Nelson KC. An acrochordon-like melanoma metastasis. Arch Dermatol 148(1):136-7, 2012. e-Pub 2012. PMID: 22250257.
      52. Raymond AK, Singletary HL, Nelson KC, Sidhu-Malik NK. Dermatomal sclerodermoid graft-vs-host disease following varicella-zoster virus infection. Arch Dermatol 147(9):1121-2, 2011. e-Pub 2011. PMID: 21931063.
      53. Tcheung WJ, Marcello JE, Puri PK, Abernethy AP, Nelson KC. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma. J Am Acad Dermatol 65(2):e37-e42, 2011. e-Pub 2011. PMID: 21075477.
      54. Tcheung WJ, Bellet JS, Prose NS, Cyr DD, Nelson KC. Clinical and dermoscopic features of 88 scalp naevi in 39 children. Br J Dermatol 165(1):137-43, 2011. e-Pub 2011. PMID: 21410662.
      55. Handler MZ, Mruthyunjaya P, Nelson K. Melanoma-associated retinopathy: a presenting sign of metastatic disease. J Am Acad Dermatol 65(1):e9-11, 2011. e-Pub 2011. PMID: 21679809.
      56. Marks V, Tcheung WJ, Burton C, Selim A, Nelson K. Reflectance confocal microscopy features of angioma serpiginosum. Arch Dermatol 147(7):878, 2011. e-Pub 2011. PMID: 21768499.
      57. Raymond AK, Puri PK, Selim MA, Tyler DS, Nelson KC. Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb. Arch Dermatol 146(12):1438-9, 2010. e-Pub 2010. PMID: 21173337.
      58. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass LF, Grekin RC, Kessinger A, Lee NY, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Perlis CS, Rosenberg EW, Shaha AR, Urist MM, Wang LC, Zic JA. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 8(8):836-64, 2010. e-Pub 2010. PMID: 20870631.
      59. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass LF, Grekin RC, Hallahan DE, Kessinger A, Lee NY, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Oseroff AR, Perlis CS, Rosenberg EW, Shaha AR, Urist MM, Wang LC, Carcinoma Panel NMC. Merkel cell carcinoma. J Natl Compr Canc Netw 7(3):322-32, 2009. e-Pub 2009. PMID: 19401064.
      60. Nelson KC, Morrell DS. Spreading bumps: molluscum contagiosum in the pediatric population. Pediatr Ann 36(12):814, 816-8, 2007. e-Pub 2007. PMID: 18229524.
      61. Nelson KC, Zhao M, Schroeder PR, Li N, Wetsel RA, Diaz LA, Liu Z. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest 116(11):2892-900, 2006. e-Pub 2006. PMID: 17024247.
      62. Byerly FL, Nelson KC, Granko RP, Morrell DS, Cairns BA. Valdecoxib-associated acute generalized exanthematous pustulosis. Burns 31(3):383-7, 2005. e-Pub 2005. PMID: 15774300.
      63. Black TA, Nelson E, Teixeira A, Anthon T, Simon J, KC <. Innovations in Dermoscopy Training: A Comparative Analysis of Dermoscopy Training Educational Delivery Models for Resident Physicians. Derm Pract Concept.

      Invited Articles

      1. Nelson K. Patient Safety and Quality Care. Clinics in Dermatology 32:542- 544, 2014. e-Pub 2014.
      2. Taylor, M, Nelson KC, Dimitriou F. Skin Cancer Precursors: From Genomics to Early Diagnosis. Hematology/Oncology Clinics of North America.

      Review Articles

      1. McQuitty EN, Black TA, Rousseau MA, Parvathaneni A, Gonna N, Farris DP, Nelson KC. Retrospective operationalization of allostatic load in patients with cancer: A systematic review. Psychoneuroendocrinology 167:107085, 2024. e-Pub 2024. PMID: 38833997.
      2. Taylor MM, Nelson KC, Dimitriou F. Skin Cancer Precursors: From Cancer Genomics to Early Diagnosis. Hematol Oncol Clin North Am 38(4):851-868, 2024. e-Pub 2024. PMID: 38782646.
      3. Haff PL, Jacobson A, Taylor MM, Schandua HP, Farris DP, Doan HQ, Nelson KC. The New Media Landscape and Its Effects on Skin Cancer Diagnostics, Prognostics, and Prevention: Scoping Review. JMIR Dermatol 7:e53373, 2024. e-Pub 2024. PMID: 38587890.
      4. Valek SA, Rousseau MA, Nelson KC, Kannler C, Tran T. Melanoma risk among career firefighters: A systematic review of case-control studies. J Am Acad Dermatol 88(5):1189-1192, 2023. e-Pub 2023. PMID: 36592739.
      5. Tran T, Rousseau MA, Farris DP, Bauer C, Nelson KC, Doan HQ. The social vulnerability index as a risk stratification tool for health disparity research in cancer patients: a scoping review. Cancer Causes Control 34(5):407-420, 2023. e-Pub 2023. PMID: 37027053.
      6. Tran T, Song S, Texeira AJ, Rechis R, Nelson KC. Educational interventions to promote sun-protection behaviors in adolescents in the United States: A systematic review. Pediatr Dermatol 40(4):637-641, 2023. e-Pub 2023. PMID: 37160666.
      7. Tran T, Ternov NK, Weber J, Barata C, Berry EG, Doan HQ, Marghoob AA, Seiverling EV, Sinclair S, Stein JA, Stoos ER, Tolsgaard MG, Wolfensperger M, Braun RP, Nelson KC. Theory-Based Approaches to Support Dermoscopic Image Interpretation Education: A Review of the Literature. Dermatol Pract Concept 12(4):e2022188, 2022. e-Pub 2022. PMID: 36534519.
      8. Najmi M, Tran T, Witt RG, Nelson KC. Modulation of the Gut Microbiome to Enhance Immunotherapy Response in Metastatic Melanoma Patients: A Clinical Review. Dermatol Ther (Heidelb) 12(11):2489-2497, 2022. e-Pub 2022. PMID: 36153786.
      9. Tran T, Ternov NK, Weber J, Barata C, Berry EG, Doan HQ, Marghoob AA, Seiverling EV, Sinclair S, Stein JA, Stoos ER, Tolsgaard MG, Wolfensperger M, Braun RP, Nelson KC. Instructional Strategies to Enhance Dermoscopic Image Interpretation Education: a Review of the Literature. Dermatol Pract Concept 12(4):e2022189, 2022. e-Pub 2022. PMID: 36534542.
      10. Gonna N, Tran T, Bassett RL, Farris DP, Nelson KC. Sensitivity and Specificity for Skin Cancer Diagnosis in Primary Care Providers: a Systematic Literature Review and Meta-analysis of Educational Interventions and Diagnostic Algorithms. J Cancer Educ 37(5):1563-1572, 2022. e-Pub 2022. PMID: 35834156.
      11. Brown AE, Najmi M, Duke T, Grabell DA, Koshelev MV, Nelson KC. Skin Cancer Education Interventions for Primary Care Providers: A Scoping Review. J Gen Intern Med 37(9):2267-2279, 2022. e-Pub 2022. PMID: 35710666.
      12. Posada EL, Lauck KC, Tran T, Krause KJ, Nelson KC. Educational Interventions to Support Primary Care Provider Performance of Diagnostic Skin Cancer Examinations: A Systematic Literature Review. J Cancer Educ. e-Pub 2022. PMID: 35040018.
      13. Seervai RNH, Cho WC, Chu EY, Marques-Piubelli ML, Ledesma DA, Richards K, Heberton MM, Nelson KC, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL. Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy. J Cutan Pathol 49(1):61-81, 2022. e-Pub 2022. PMID: 34622477.
      14. Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol 156(9):1004-1011, 2020. e-Pub 2020. PMID: 32725204.
      15. Grossman D, Kim CC, Hartman RI, Berry E, Nelson KC, Okwundu N, Curiel-Lewandrowski C, Leachman SA, Swetter SM. Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice. Melanoma Manag 6(4):MMT32, 2019. e-Pub 2019. PMID: 31871621.
      16. Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Meyskens FL, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer 125(1):18-44, 2019. e-Pub 2019. PMID: 30281145.
      17. Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma Manag 4(1):13-37, 2017. e-Pub 2017. PMID: 28758010.
      18. Kim CC, Swetter SM, Curiel-Lewandrowski C, Grichnik JM, Grossman D, Halpern AC, Kirkwood JM, Leachman SA, Marghoob AA, Ming ME, Nelson KC, Veledar E, Venna SS, Chen SC. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. JAMA Dermatol 151(2):212-8, 2015. e-Pub 2015. PMID: 25409291.
      19. Voss RK, Woods TN, Cromwell KD, Nelson KC, Cormier JN. Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis. Patient Relat Outcome Meas 6:229-42, 2015. e-Pub 2015. PMID: 26609248.
      20. Kim JK, Nelson KC. Dermoscopic features of common nevi: a review. G Ital Dermatol Venereol 147(2):141-8, 2012. e-Pub 2012. PMID: 22481577.

      Editorials

      1. Adamson AS, Nelson KC. Observation of Moderately Dysplastic Nevi With Positive Margins: Are We There Yet?. JAMA Dermatol 154(12):1387-1388, 2018. PMID: 30304351.
      2. Love PB, Nelson KC. Melanoma of the hand and foot: a distinct clinical variant of cutaneous melanoma. Br J Dermatol 166(4):708, 2012. PMID: 22452435.

      Book Chapters

      1. Navarette-Dechent C, Nelson K, Rossi A, Lee E, Barker C, Nehal K, Swetter S. Lentigo Maligna Melanoma. In: Cutaneous Melanoma. Springer Nature, 2018.
      2. Nelson K, Ning L, Liu Z, Diaz L. The Pemphigoid Spectrum. In: Clinical Immunodermatology. Springer Publishing, 2008.
      3. Nelson K, Morrell D, Rubenstein D. Eczema and other Common Disorders. In: Netter's Internal Medicine. Icon Learning Systems, 2008.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top